However, several studies have demonstrated that SOCS3 mediates insulin resistance in both adipocytes and hepatocytes through post-translational modifications such as inhibition of IRS tyrosine phosphorylation [50] and targeted ubiquitin-mediated degradation of IRS1 and IRS2 without effecting transcription [49, 51]. The gene discussed is SOCS3; the disease is Insulin resistance.